Skip to main content

December 16, 2020

Research findings of Stephan Moll, MD and Luis Malpica, MD educational session during ASH

Improving Immunizations in Patients with Non-Malignant Hematological Disorders Receiving Immunosuppressive Therapy article Based on research findings of Drs. Malpica and Moll Read article, ASH invited Dr. Moll to moderate and Dr. Malpic to present at an  education session on “Preventing Infections when treating non-malignant hematology disorders” at the annual ASH meeting on Dec 7, 2020. …

September 27, 2020

Vaibhav Kumar MD, Hematology-Oncology fellow, publishes study defining improved thresholds for thrombosis prophylaxis in cancer in the ‘The Oncologist’”

The Oncologist “D-dimer enhances risk targeted thromboprophylaxis in ambulatory cancer patients” Background:  Thromboprophylaxis for ambulatory cancer patients is effective, although uncertainties remain on who should be targeted.  using D-dimer values from individuals enrolled to the AVERT trial, we sought to identify and validate a more efficient VTE risk threshold for thromboprophylaxis. Read Publication here